KT

Kyverna Therapeutics

KYTX

NASDAQHealth Care

Income Statement

Total Revenue$0

Operating Income$0

EBITDA$0

EBIT$-160.65M

Pre-tax Income$-145.42M

Net Income$-145.42M

Balance Sheet

Cash Equivalent$242.65M

Total Debt$580K

Book Value$266.59

Book Value Per Share6.17

Key Ratios

Return on Equity (ROE)-47.64%

Return on Assets (ROA)-41.69%

Return on Invested Capital (ROI)-47.48%

Net Profit Margin-411.29%

Current Ratio8.61

Quick Ratio8.47

Long-Term Debt / Equityundefined